Work

Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma

Year: 2019

Type: review

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.03.017

Authors: Faiz Anwer, Kevin Mathew Gee, Ahmad Iftikhar, Mirza Baig, Atlantis Dawn Russ, Sabina Saeed, Muhammad Abu Zar, Faryal Razzaq, Jennifer Carew, Steffan Nawrocki, Hussam Al-Kateb, Nadia Nunes Cavalcante Parr, Ali McBride, Jason Valent, Christy Samaras

Institutions: Cleveland Clinic, University of Arizona, Summit Medical Group (United States), Cincinnati Children's Hospital Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1361187950, Development of lysosome targeted therapeutics

OpenAlex ID: W2922878699

FWCI: 0.596

Cites: 139

Cited by: 23

Related to: 10